Evidence map›Paper›PMID 28488999›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2017

Immunisation Information Systems - useful tools for monitoring vaccination programmes in EU/EEA countries, 2016.

Tarik Derrough, Kate Olsson, Vincenza Gianfredi, Francois Simondon, Harald Heijbel, Niklas Danielsson, Piotr Kramarz, Lucia Pastore-Celentano

Open access · diamondAbstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 3 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 3 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Tarik DerroughEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Kate OlssonEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Vincenza GianfrediSchool of Specialization in Hygiene and Preventive Medicine, Department of Experimental Medicine, University of Perugia, Perugia, Italy.
Francois SimondonMother and Child Health research unit 216, IRD & Paris Descartes University, France.
Harald HeijbelRet. Swedish Institute for Infectious Disease Control (SMI), Stockholm, Sweden.
Niklas DanielssonEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Piotr KramarzEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Lucia Pastore-CelentanoEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
European Centre for Disease Prevention and Control · SEUniversité Paris Cité · FRUniversity of Perugia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunisation Information Systems (IIS) are computerised confidential population based-systems containing individual-level information on vaccines received in a given area. They benefit individuals directly by ensuring vaccination according to the schedule and they provide information to vaccine providers and public health authorities responsible for the delivery and monitoring of an immunisation programme. In 2016, the European Centre for Disease Prevention and Control (ECDC) conducted a survey on the level of implementation and functionalities of IIS in 30 European Union/European Economic Area (EU/EEA) countries. It explored the governance and financial support for the systems, IIS software, system characteristics in terms of population, identification of immunisation recipients, vaccinations received, and integration with other health record systems, the use of the systems for surveillance and programme management as well as the challenges involved with implementation. The survey was answered by 27 of the 30 EU/EEA countries having either a system in production at national or subnational levels (n = 16), or being piloted (n = 5) or with plans for setting up a system in the future (n = 6). The results demonstrate the added-value of IIS in a number of areas of vaccination programme monitoring such as monitoring vaccine coverage at local geographical levels, linking individual immunisation history with health outcome data for safety investigations, monitoring vaccine effectiveness and failures and as an educational tool for both vaccine providers and vaccine recipients. IIS represent a significant way forward for life-long vaccination programme monitoring.

Indexed as

Information SystemsVaccinesCross-Sectional StudiesEuropeEuropean UnionHumansImmunization ProgramsPublic HealthRegistriesVaccinationVaccinesEuropean Unionimmunisationimmunisation information systemsvaccination coveragevaccines

Identifiers

PMID28488999
PMCPMC5434883
OpenAlexW2612241155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.